Interarm BP difference may up cardiac risk in diabetes

Interarm BP difference may up cardiac risk in diabetes

(HealthDay)—Interarm differences in systolic blood pressure (BP) in patients with diabetes may be associated with an increased risk of cardiovascular morbidity and mortality, according to research published online on March 25 in Diabetes Care.

Christopher E. Clark, Ph.D., of the University of Exeter in the United Kingdom, and colleagues analyzed data from a prospective cohort of 727 patients with type 1 or type 2 diabetes and 285 controls without diabetes. The authors sought to assess the association between interarm differences in BP and risk of and mortality.

The researchers found that interarm differences of 10 mm Hg or greater in systolic BP in patients with diabetes were associated with increased risk of (odds ratio [OR], 3.4; 95 percent confidence interval [CI], 1.2 to 9.3). Interarm differences of 15 mm Hg or greater in systolic BP in patients with diabetes were associated with increased risk of diabetic retinopathy (OR, 5.7; 95 percent CI, 1.5 to 21.6) and chronic kidney disease (OR, 7.0; 95 percent CI, 1.7 to 29.8). Interarm differences in systolic BP were associated prospectively with increased risk of cardiovascular mortality (hazard ratios: 10 mm Hg or greater, 3.5 [95 percent CI, 1.0 to 13.0] and 15 mm Hg or greater, 9.0 [95 percent CI, 2.0 to 41.0]).

"In the population with , systolic differences may be associated with an increased risk of morbidity and mortality," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Ideal BP for kidney disease patients may be 130-159/70-89

Aug 21, 2013

(HealthDay)—In patients with chronic kidney disease (CKD), optimal blood pressure (BP) seems to be 130 to 159/70 to 89 mm Hg, according to a study published in the Aug. 20 issue of the Annals of Internal Me ...

Clopidogrel after MI less effective in diabetes patients

Sep 05, 2012

(HealthDay)—Clopidogrel therapy following a heart attack does less to reduce the risk of death in patients with diabetes than in those without diabetes, according to a study published in the Sept. 5 issue ...

Recommended for you

Progress in diabetes drug delivery

Jan 22, 2015

A drug therapy for diabetes treatment is being developed by an international research team led by WA scientists, which combines an existing anti-diabetic drug with bile acids to improve the drug's delivery ...

Roux-en-Y surgery can reverse insulin treatment in T2DM

Jan 21, 2015

(HealthDay)—Roux-en-Y gastric bypass surgery (RYGB) strongly predicts insulin cessation after surgery in insulin-treated type 2 diabetes (I-T2D) patients, independent of weight loss, according to a study ...

Unexpected turn in diabetes research

Jan 20, 2015

Years of diabetes research carried out on mice whose DNA had been altered with a human growth hormone gene is now ripe for reinterpretation after a new study by researchers at KU Leuven confirms that the gene had an unintended ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.